ArticleOpen medicine (Warsaw, Poland)2022

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway.

Lu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.